Life demands excellence
RM M A G A Z I N E AUTUMN 2018
DIGITAL DIAGNOSIS How researchers are harnessing the power of big data and artificial intelligence Our Oak Cancer Centre Appeal passes the halfway mark The NHS at 70: our milestones
RM36_p01_cover_v4.0.indd 1
10/09/2018 17:03
At The Royal Marsden, we deal with cancer every day, so we understand how valuable life is. And when people entrust their lives to us, they have the right to demand the very best. That’s why the pursuit of excellence lies at the heart of everything we do.
2 RM magazine
RM36_p02-03_intro_v4.0.indd 2
05/09/2018 15:59
EXECUTIVE NOTES
CONTENTS 4 Bulletin What’s happening around The Royal Marsden 12 70 years of innovation A timeline of our achievements since the NHS was founded 14 Party at the Palace Celebrating our work at Buckingham Palace 18 Oak’s major gift The Oak Cancer Centre is set to become a reality 20 A day in the life Why Staff Nurse Nadia Freri is inspired by her young patients 22 Smart work Big data and AI are improving the options for treatment 25 It happened to me Julie Morawaka on regaining her confidence after major surgery 26 Fundraising News from The Royal Marsden Cancer Charity 28 Foundation news Updates from our Foundation Trust and Governors
WELCOME to the autumn 2018 edition of RM, the magazine for our staff, patients, carers and Foundation Trust members. In this issue, we look back at two celebrations. The first is the NHS’s 70th birthday and The Royal Marsden’s key achievements over its seven decades (pages 4, 11 and 12). The second is the dinner we held at Buckingham Palace to celebrate the work of The Royal Marsden and The Royal Marsden Cancer Charity (page 14). The event was attended by those who have helped the Charity go past the halfway point in its £70-million fundraising appeal to build a state-of-the-art facility, the Oak Cancer Centre (see page 18). We also look ahead to a new era of exploring how big data and artificial intelligence (AI) can be used in the diagnosis, treatment and care of people with cancer (page 22). Dr Christina Messiou, Consultant Radiologist, talks about our partnership with Imperial College London, which is exploring the use of AI to assist radiologists to report on whole-body MRI scans. And on page 20, we hear from one of our paediatric nurses in the Oak Centre for Children and Young People and find out how she and her colleagues make a difference to children’s lives. I hope you enjoy reading this issue of RM.
30 Puzzles and prizes Test your wits and win a prize with our crossword 31 Stay in touch Your comments on social media, plus hospital contacts
Cally Palmer CBE, Chief Executive, The Royal Marsden
ON THE COVER Dr Christina Messiou, Consultant Radiologist
RM magazine 3
RM36_p02-03_intro_v4.0.indd 3
13/09/2018 15:04
B U L L E T I N W H AT ’ S H A P P E N I N G A R O U N D T H E R O YA L M A R S D E N
Nursing times CONTINUING OUR SERIES of archive images to celebrate the 70th birthday of the NHS, this photo dates back to about 1967 and shows a patient being attended to by a nurse in the Post-Operative Recovery Ward, where patients were kept for 24 hours following surgery. In the 1960s, Royal Marsden nurses changed the face of nursing by opening up opportunities for education and professional development. Our first-ever sister tutor, Pamela Newbury, who later became Matron, started running a post-registration cancer care course in 1961. In 1965, we appointed our first-ever senior male Matron, Graham Joyson, who introduced the specialist nurse concept to the hospital. By the 1970s, we brought in study days and short courses, and by 1976, more than 2,000 nurses, students and visitors had visited The Royal Marsden to learn about our nursing and nurse training methods.
4 RM magazine
RM36_p04-05_News_v4.0.indd 4
05/09/2018 15:57
? DID YOU KNOW? Katie’s Lymphoedema Fund, set up to support The Royal Marsden Cancer Charity, funds professional training courses in the management and treatment of lymphoedema at The Royal Marsden School.
ALTERED IMAGES Miss Jennifer Rusby led a study of breast measurement
Breast measurement system shapes up IMAGING EQUIPMENT THAT is more commonly used for cosmetic surgery may have the potential to assist in surgical planning for breast cancer patients, new research suggests. The Royal Marsden is one of only a handful of centres in the UK using the Vectra XT three-dimensional imaging system for treating women with breast cancer. Miss Jennifer Rusby, Consultant Oncoplastic Breast Surgeon, led a study that aimed to validate breast symmetry and volume measurements provided by the system. If the measurements given by the imaging system can be accurately validated – and therefore be repeatable – it means surgeons can better understand the natural changes in shape that occur over time after breast cancer surgery. This, in turn, will allow them and nursing
colleagues to better prepare patients for what lies ahead. Miss Rusby said: “By validating the measurements provided by the Vectra XT, we can confidently use the system to plan and evaluate aesthetic outcomes for our patients.” Carol Pitches was a participant in the study and helped to shape the early funding application as a patient and public involvement (PPI) colleague. Carol said: “Like anyone who is diagnosed, I was concerned not just about having the surgery and the recovery, but also how I would look dressed and facing the world. Would it be obvious that I had one natural and one reconstructed breast? “I believe this imaging option helps patients feel more engaged with their treatment and, with more personalised information before the operation, have a greater sense of certainty about the outcome.” RM magazine 5
RM36_p04-05_News_v4.0.indd 5
05/09/2018 15:57
One for the boys The Royal Marsden welcomes the government’s decision to extend immunisation against HPV ( human papillomavirus) to adolescent boys, following advice from the Joint Committee on V accination and Immunisation ( JCV I) . HPV is the name given to a large group of viruses that can be caught through any kind of sexual contact. Although most HPV infections go away by themselves, others can lead to cancer. V accinating girls against HPV brings down the incidence of cervical cancer, while boys would be protected to some extent against developing cancers of the anus, penis, mouth and throat. D r Nicholas van As, Medical D irector and Consultant Clinical O ncologist at The Royal Marsden, said: “The recommendation to extend HPV vaccination to boys is a very positive move as it will provide herd immunity, increasing protection for both sexes. There has been a si nificant rise in the incidence of HPV related head, neck and anal cancers in both women and men, so this would have a si nificant i pact and potentially save thousands of lives.” The HPV vaccine is routinely o ered to girls aged 1 2 to 1 3 at secondary school.
RECRUITING NOW Staff Nurses Judelle Tomaszewska (left) and Shane Bellot are from the Philippines
Transforming the nursing workforce THE ROYAL MARSDEN is starting to reap the benefits of nurse recruitment projects. Our first trainee nurse associates (TNAs) are now halfway through their two-year Nursing Associate Scheme, which offers healthcare support workers (HCSWs) the opportunity to develop their skills and go on to qualify as registered nurses. Trainee Nurse Associate Lisa Norton said: “I was a healthcare assistant for six years. This course has given me a wonderful opportunity to advance my nursing career.”
We have also been supporting HCSWs who were previously working as qualified nurses in their native countries to complete training to become registered nurses at The Royal Marsden. Judelle Tomaszewska is one of the first three such nurses to complete the programme. She said: “I was a nurse for four years in the Philippines, but here I could only work as a healthcare assistant. I’m now very proud to be a staff nurse at The Royal Marsden.” In addition to this, our International Nurse
Recruitment programme recruits nurses, mainly from the Philippines, whose visa sponsorship requires them to achieve registration within eight months of arrival. We provide support to help settle our international nurses in the UK, such as assisting with accommodation. Eamonn Sullivan, Chief Nurse, said: “Skilled and experienced nurses are vital to delivering excellent patient care, so we must look at ways to both attract the best candidates and to support our existing staff to develop.”
6 RM magazine
RM36_p06-07_News_v4.1.indd 6
13/09/2018 13:40
taff survey re
uality of non mandatory training learning or uality of non mandatory t Our top scores nationally esponse rate increased by eventh most improved rust across teach esponse rate increased by to development e are ranked rst across teaching hospitals development
esponse rate increased by for to bove airness average in of indicators and effectiveness of procedures e are ranked rst across teaching hosp Key finding airness and effectiveness Our top scores nationally Ourchieved topreporting scores nationally errors near misses and indicators bestbove scores nationally for nine indicators errors near misse average inreporting of indicators Our top scores nationally uality of non mandatory tra recommendation ofrust the organisation as a hospital eventhtaffmost improved across teaching ON TARGET finding development chieved best scores nationally nine Key finding taff recommendation of th FOR TARGETEDfor 2016 place to work orKey receive treatment esponse rate increased by to Key finding RADIOTHERAPY place to work or receive tre BULLETIN
Staff survey eventh most improved rust across tea uality oflearning non mandatory trai airness and effectiveness of uality of non mandatory training or puts us development on top of staff able to contribute to improvements uality of nonreporting mandatory training learning or development errors near misses F inal preparations are now under way to treat the first patient in the U K on the Magnetic Resonance L inear Accelerator ( MR L inac) , a pioneering machine that combines an MR scanner and linear accelerator. DID YOU D r Alison Tree, KNOW? Consultant Clinical The Royal O ncologist, said: Marsden has “The location of been shortlisted tumours and organs for the Best UK changes from day Employer of the to day; for example, Year Award in the prostate might the Nursing move depending on Times the fullness of the Workforce patient’s bowel. W e Awards. will be able to see organs much more clearly than before, ensuring we can deliver radiotherapy more precisely and healthy tissue with beingavoid the highest and The MR L inac was made possible by a £ 1 0 -million grant from the Medical Research Council to The Institute of Cancer Research, with support from The Royal Marsden Cancer Charity.
esponse rate increased by to Our top scores nationally development of staff able to contribute THE ROYAL MARSDEN has been ranked as the top-performing trust among UK teaching hospitals in the 2017 National NHS Staff Survey, carried out every year.
Our response rate increased from 48 per cent the year before to 54 per cent in 2017, and we achieved the best scores nationally for the nine indicators below:
airness and effectiveness of taff recommendation of the airness and effectiveness of procedures for airness effectiveness of procedures for ffective team working reporting errors misses errors near and misses andtoindicators place work or near receive treatm Key findingreporting 2016 20 Our top scores nationally
reporting errors near misses and indicators ffective team working ? recommendation taff recommendation oftraining thetaff organisation a of the o uality of nonand mandatory learning oras ecognition value of staff by managers and taff recommendation of the organisation as a4t of staff ableortoreceive contribute place to work treatm Key development place tofinding workplace or receive treatment the organisation to work or receive treatment
Quality of non-mandatory training, learning or development
Fairness and
Staff recommendation
ecognition and value of st
of the organisation effectiveness of airness and effectiveness of procedures fortraining learning uality of non mandatory of staff reporting good communication as a place to work or procedures for the organisation 4 of staff able to contribute to of staff able to contribute to improvements receive treatment reporting errors, near ffective team working reporting errors near misses and indicators of staff able to contribute to improvements development between senior management and staff misses and indicators
of staff reporting good co taff recommendation of and the organisation asofa procedures airness effectiveness fo 4 ecognition and value of staff between senior manageme ffective use of patient or service user feedback ffective team working ffective team working place to work orreporting receiveteam treatment ffective working errors near misses and indicator
the organisation Effective use of patient Effective team working Recognition and value of taff recommendation the organisation value of of staff by managers an ecognition and value of staff managers and ofstaff staffable e periencing physical violence from or service user and value of staff staff by managers andand of toecognition contribute to ecognition improvements 7 ffective use of patient or sa ofby staff reporting good com feedback the organisation place to workbetween or organisation receive treatment organisation staff in last the months the organisation the senior management ercentages are out of andreporting absolute are out of of being of scores staff reporting good communication ffective team working 3 of staff good communication of staff e periencing phy staff reporting good com of staff able to contribute to improvemen between seniorbetween management and staff or ser between senior management andinstaff ffective use of patient senior management staff last months
ecognition and value of staff by managers and Highest percentage of Lowest percentage of staff Becausethe of you have beenphysical able to achieve these amazing r3 staff able we to contribute experiencing ercentages are out of and absolute scores are ou organisation ffective use of patient or service user feedbac to improvements violence from staff in service team working ffective use offfective patient or user of staff e feedback periencing physi
Highest percentage of staff reporting good communication between senior management and staff
ffective use of patient or serv thank you. staff in last months of staff reporting good communication the last 12 months
of staff e periencing physical violence from4 ecognition and value of staff by managers between senior management and staff of staff e periencing physical violence from staffwe e absolute periencing physic Because ofof havescores beenare able ofyou and out o staff in last are out months theercentages organisation
staff in last Top-ranking CQC inpatient results
months
staff in last months ercentages out of andPalmer, absolute out of Marsden, with said: being the high Cally Chief E scores xecutive offeedback The Royal The Royal Marsden has been ranked as use one ofare the ffective ofbest patient or service userare 4 of staff reporting good communication “The surveys provide essential feedback that will be used to places in E ngland are to receive to recent results ercentages out care, of according and absolute scores are out of with being the highest and bein ercentages are out of and absolute scores are out of ensure continuous improvement. D espite doing exceptionally published by the Care Q uality Commission ( CQ C) . Because of you we haveand been able t senior management well, there are always areas we can improve on and we takestaff In the annual adult inpatient survey, which looks atbetween the staff e Royal periencing physical violence all patient feedback extremely seriously.from experiences of patients in allof NHS trusts, The Marsden Because we have been able totheachieve these “The Trust is grateful to everyone who took time tothank was ranked second in E ngland for patient experienceof and you rated staff in last months complete the survey. I am extremely proud of the results 9 .1 out of 1 0 . W e had consistently high scores from almost Because of you we have been able to achieve these amazing of you we been able and the wor that sta do to achieve the 6 0 0 inpatients who completed the survey in September 2 ffective 0 1 7.Because use ofour patient orhave service user feedto thank you. ercentages are out of
RM36_p06-07_News_v5.0R.indd 7
than
being the highest and being the thank with you. thank
and absolute scores are out of
RM magazine 7
of staff e periencing physical violence fr 17/09/2018 10:22
TOOL PREDICTS RISK OF BREAST CANCER RETURN A new, simple web-based calculator for clinicians that could better predict the long-term risk of breast cancer returning has been developed by researchers at The Royal Marsden and Q ueen Mary U niversity of L ondon. The prognostic tool – called CTS5 – could be used to help identify which patients have a high risk of recurrence and should extend their hormone therapy beyond the standard five years and which patients are at low risk and would not enefit eanin they can avoid any potential adverse side e ects B ased on recently published research, co-lead author Professor Mitch D owsett, Head of The Royal Marsden Ralph L auren Centre for B reast Cancer Research, believes that CTS5 will improve clinical practice and provide clinicians with the best tools to help them make crucial decisions.
ASSESSING LONG-TERM RISK Professor Mitch Dowsett
SCREEN TEST RM Partners aims to improve the rates of cervical screening
Making cancer screening accessible for all ROYAL MARSDEN PARTNERS (RM Partners) is one of 19 cancer alliances across England and covers a population of over four million. It is piloting new delivery models for cancer care across northwest and southwest London. The earlier cancer is diagnosed, the more likely it is that treatment will be successful. But attendance of cervical screening is at a 20-year low, with an uptake as low as 54 per cent in some parts of west London – the national target is 80 per cent. RM Partners’ approach is to increase screening clinics in accessible locations near public transport and on evenings and weekends. The project involves recruiting extra practice nurses and administrative staff. Working with Hammersmith & Fulham, Merton and Wandsworth GP Federations, the project will run for a year. RM Partners has also provided funding to the North West London Collaboration of Clinical Commissioning Groups (CCGs) to run similar clinics in other boroughs.
RM Partners has commissioned London charity Community Links to increase the number of people taking part in the national bowel cancer screening programme, which is as low as 36 per cent in parts of west London against the national target of 60 per cent. The one-year pilot involves Community Links contacting eligible residents by telephone to talk them through the process. In Wandsworth alone, more than 6,000 phone calls have been made to date and almost 2,500 misplaced home screening kits reordered, which it is estimated will result in an additional 600 people being screened. RM Partners is also collaborating with Kingston Public Health and Kingston CCG to target marginalised people. The one-year pilot is designed to engage patients who do not typically respond to traditional methods of screening invitation, such as those with a learning disability, the homeless, refugees and asylum seekers, and those who speak English as a second language.
8 RM magazine
RM36_p08-09_News_v4.0.indd 8
05/09/2018 15:03
BULLETIN
Chicago presentations from our clinicians ROYAL MARSDEN CLINICIANS travelled to Chicago for the American Society of Clinical Oncology’s (ASCO) Annual Meeting in June, where they presented the latest advances in cancer research and care. A keynote lecture from Professor Johann de Bono, Honorary Consultant in Medical Oncology, revealed findings from the first clinical trial to show the benefits of immunotherapy in prostate cancer for some men with advanced, otherwise untreatable disease. Led by The Royal Marsden and The Institute of Cancer Research, the international trial could lead to a subset of prostate cancers
Immunotherapy could be used to treat some prostate cancers
joining the list of diseases that can be treated with immunotherapy. Michael English, 72, was treated with pembrolizumab at The Royal Marsden’s West Wing Clinical Research Centre in 2016. He said: “Professor de Bono recommended pembrolizumab based on a genetic test and, after only a few threeweekly cycles, we were astonished when scans showed that the tumour was undetectable. With a fourth grandchild on the way, my wife and I can now plan for the next 20 years, instead of the next two.” An education session by Dr Susana Banerjee addressed the latest evidence on physician burnout. Its impact on physicians, patients and institutions has become increasingly apparent, and Dr Banerjee’s session focused on solutions and strategies for tackling it, while incorporating her own perspective as an oncologist.
5
FAST FACTS Oak Cancer Centre for Children and Young People (OCCYP)
1 in 500 patients under 15 years of age are affected by cancer in the UK
£18m The cost of the OCCYP, funded by The Royal Marsden Cancer Charity
600
inpatients are seen in the OCCYP each year
150k
meals have been served in the OCCYP’s two kitchens since it opened in 2011
STRATEGIC THINKING Dr Susana Banerjee led an education session on physician burnout
30
young patients are treated on trials of molecularly targeted agents and immunotherapy every year RM magazine 9
RM36_p08-09_News_v4.0.indd 9
05/09/2018 15:03
IN BRIEF
Patient pack
The Royal Marsden has launched a new patient welcome pack. Funded by The Royal Marsden Cancer Charity, the small recyclable box includes ear plugs, an eye mask, anti-bacterial wipes, fall prevention socks and a dental kit.
Admissions assistance
The Trust is introducing a team of physician associates, who will manage elective admissions in the Gastrointestinal, Head and Neck, Thyroid and U rology units in Sutton. D r Jaishree B hosle, D eputy D irector of Medical E ducation, said: “This will reduce non-emergency waiting times and improve continuity of care for elective patients.”
Videofluoroscopy service in Sutton
The Royal Marsden’s Speech and Language Therapy team has launched a state-ofthe-art videofluoroscopy service in Sutton. Working with radiology colleagues, videofluoroscopy will help us diagnose and treat dysphagia (difficulty swallowing) resulting from cancer and treatment side effects, and subsequently improve patients’ quality of life.
Q&A: CIRCULATING TUMOUR DNA Khurum Khan, Clinical Research Fellow, explains why researchers are looking at tumour DNA in the blood to predict how patients will respond to treatment Q What is circulating tumour DNA? A Tiny fragments of DNA, which are released into the bloodstream by cancer cells. Q Why are researchers interested in them? A They can be picked up by a simple blood test, also known as a liquid biopsy, which is quicker, cheaper and less invasive than a
tissue biopsy. By analysing the DNA for minute genetic alterations, we can follow the progression of a patient’s tumour over time and predict whether they will respond to a particular treatment. Q What is The Royal Marsden doing? A In collaboration with The Institute of Cancer
Research (ICR), we’ve carried out two major clinical studies on circulating tumour DNA in patients with bowel cancer. In these studies, published in the journals Gut and Cancer Discovery, we’ve been able to predict which patients will respond to regorafenib and cetuximab, two important treatments for bowel cancer. This research wouldn’t have been possible without the unique collaboration between teams at The Royal Marsden, led by Professor David Cunningham, and the ICR, led by Dr Nicola Valeri. We have a dedicated biological specimen team in Chelsea and Sutton, which means blood tests are processed and ready to send to the ICR for further analysis within 30 minutes. Q How might this work influence cancer treatment? A Patients with advanced bowel cancer have limited treatment options, so we need tests that quickly identify whether they are likely to benefit from a particular treatment. This means we can avoid giving patients a drug we know won’t work for them and can consider alternative treatments at a much earlier stage. At The Royal Marsden, targeted, precision medicine is crucial and these studies mean we can select the right treatment for the right patient, at the right time.
“By analysing the DNA for minute genetic alterations, we can follow the progression of a patient’s tumour”
10 RM magazine
RM36_p10-11_News_v3.0.indd 10
07/09/2018 15:28
BULLETIN
Remembering Don
Celebrating the NHS
? AN INSPIRATION Don McCarthy meets our President, HRH The Duke of Cambridge
ROYAL MARSDEN CANCER CHARITY donor Don McCarthy CBE passed away in July this year after being diagnosed with cancer of the oesophagus in 2016. Don contributed £1 million towards the cost of refurbishing the Medical Day Unit, named the Diane McCarthy Medical Day Unit in memory of his late first wife. Later, Don and his children, John and Hannah, donated £1.5 million to enable the Charity to purchase a da Vinci Xi surgical robot.
DID YOU KNOW? Recently, he gave £500,000 towards the Oak Cancer Centre Appeal. Cally Palmer, Chief Executive of The Royal Marsden, said: “Don was an inspiration and had a huge impact on everyone who met him. It is thanks to donors like him that we can continue to be at the forefront of cancer treatment, care and research. “His loss will leave a huge gap in many people’s lives. Our sympathies go to John, Hannah and Don’s wife Julie.”
NEXT STOPS FOR MOBILE CHEMOTHERAPY Two new locations have been added to the Mobile Chemotherapy Unit’s weekly schedule: Lloyd Park, Croydon, and Depot Road, Epsom. This is in addition to Sainsbury’s in Selhurst Park, Croydon. The MCU was made possible by The Royal Marsden, The Royal Marsden Cancer Charity and Hope for Tomorrow. It aims to reduce the need for adult patients to travel to
hospital for chemotherapy and supportive treatments while ensuring they continue to receive expert care and treatment. It has delivered more than 300 treatments to patients in its first year; we hope to have provided 700 treatments on the MCU by the end of 2018. Patients can discuss suitability for treatment on the MCU at their outpatient appointments.
Senior MRI radiographer Georgina Hopkinson has had her first paper, on complex imaging of the liver, published in the peerreviewed journal Radiography.
O n 5 July, the NHS celebrated its 70 th birthday – and The Royal Marsden j oined in the festivities. O ur young patients at the O ak Centre for Children and Y oung People learned about the history of the NHS during the week, made birthday cards and took part in biscuit-decorating competitions. Meanwhile, members of sta includin Medical D irector D r Nick van As, Chief Nurse E amonn Sullivan and Matron Angela L ittle – met patients in reception with tea and cupcakes. W e also produced exhibition boards in both Sutton and Chelsea, highlighting our key achievements over the past 70 years ( see page 1 2 for more) . Around 2 0 members of sta attended a service at W estminster Abbey on the day. O ne was Play Specialist Caroline L angham, who said: “It was an amaz ing experience. W hile listening to the W estminster Abbey Choir, I thought about all the children and their families that The Royal Marsden has cared for. I felt very proud to work for the NHS.”
RM magazine 11
RM36_p10-11_News_v3.0.indd 11
07/09/2018 15:29
1940
s Thanks to our pioneering work in developing diagnostic X-rays, we were the first hospital in the UK to use artificial radioactive isotopes for the treatment of patients
1950s We developed the
chemotherapy drugs busulfan, chlorambucil, melphalan and carboplatin, which are still in worldwide use today
70 YE ARS OF INNOVATION
The Royal Marsden has been at the forefront of cancer treatment and research ever since the NHS was founded in 1948. These are our key milestones
1970
s The first bone marrow transplant in Europe was carried out at The Royal Marsden
Illustration: Fernando Volken Togni
2018
We were the first centre in the UK to install an MR Linac, which combines MR imaging and radiotherapy to allow us to adapt a patient’s treatment in real time RM
2011 We were one of the first NHS
trusts to introduce CyberKnife, which delivers stereotactic radiotherapy with pinpoint accuracy
2010s After trials
at The Royal Marsden, abiraterone becomes standard treatment for prostate cancer patients across the world
12 RM magazine
RM36_p12-13_NHS70_illustration_v4.0.indd 12
05/09/2018 14:53
NHS70
1992 We were the
first centre in the UK to use a multileaf collimator machine, which shapes radiation to target tumours
1990
1980
s Our trial of the drug tamoxifen showed that its use reduced the likelihood of disease developing in women deemed at risk of oestrogen receptor positive (ER+) breast cancer
s The hospital led major clinical trials in radiotherapy and imaging, such as the breast cancer START trial, which changed standard clinical practice
2000
s Our trials for the immunotherapy drugs vemurafenib and ipilimumab led to the biggest breakthrough in the treatment of metastatic melanoma for more than 30 years
2000
s We were the first hospital to treat a patient with intensity-modulated radiation therapy (IMRT)
2007 We were the first UK trust 2010 We opened our Critical
to install the da Vinci S surgical robot. This was followed by the da Vinci Xi in 2015, thanks to a donation from the late philanthropist Don McCarthy and his family
Care Unit, the only facility in the UK providing intensive care exclusively for cancer patients
2004 We were one of the
first centres in the UK to offer routine testing on the NHS for the EGFR gene mutation, affecting lung cancer patients
RM magazine 13
RM36_p12-13_NHS70_illustration_v4.0.indd 13
05/09/2018 14:53
STARRY NIGHT Kylie Minogue performs on stage for guests
PARTY AT THE PALACE Buckingham Palace was the venue in June for a special celebration of The Royal Marsden Cancer Charity’s fundraising work
14 RM magazine
RM36_p14-17_BP_v4.0.indd 14
05/09/2018 14:51
R OYA L M A R S D E N C A N C E R C H A R I T Y D I N N E R
PICTURE PERFECT From top: dinner in the Picture Gallery; the table is set; HRH The Duke of Cambridge speaks on stage
THE INNOVATIVE WORK of The Royal Marsden and The Royal Marsden Cancer Charity was celebrated at a star-studded dinner at Buckingham Palace this summer, with a musical performance from Kylie Minogue and a speech from our President, HRH The Duke of Cambridge. The Charity has launched its most ambitious appeal to date – to raise £70 million to build a brand-new cancer facility. The appeal has passed the halfway mark already, thanks to a generous gift of £25 million from Oak Foundation, which has been a long-term supporter of the Charity. Turn to page 18 for more on Oak Foundation and an update on the new Oak Cancer Centre. The Duke was joined at the dinner, held in the Palace’s Picture Gallery, by Chief Executive Cally Palmer CBE, Chairman Charles Alexander, and valued supporters of the Charity. Guests included Charity Trustee Lady Helen Taylor, Appeal Board Chairman Mike Slade, actors Olivia Colman and Tom Hiddleston, and tennis star Grigor Dimitrov. Kylie said: “It was my absolute pleasure to perform at Buckingham Palace this evening in support of The Royal Marsden Cancer Charity. The pioneering work undertaken by The Royal Marsden helps people with cancer everywhere and I, for one, am very grateful for their amazing work.” > RM magazine 15
RM36_p14-17_BP_v4.0.indd 15
05/09/2018 14:51
MEET AND GREET The Duke chats with Jette Parker, Benedikte Turner, Chloe Turner and Alan Parker of Oak Foundation (right), Olivia Colman, her husband Ed Sinclair, and Siobhán Hewlett (below), and The Royal Marsden’s Chairman Charles Alexander and Chief Executive Cally Palmer (below right)
16 RM magazine
RM36_p14-17_BP_v4.0.indd 16
05/09/2018 14:51
R OYA L M A R S D E N C A N C E R C H A R I T Y D I N N E R
“What the Charity and The Royal Marsden are doing is immeasurably important” A NIGHT TO REMEMBER The Duke meets actor Tom Hiddleston (above) and chats with former tennis player Ross Hutchins, who was treated at The Royal Marsden, and current star Grigor Dimitrov (right); guests gather in the Blue Drawing Room (below)
The evening started with a drinks reception in the Blue Drawing Room and Music Room and speeches by The Duke and Professor David Cunningham, Director of Clinical Research at The Royal Marsden. To finish the evening, Jake Coates, widower of Royal Marsden patient Emmy Coates and supporter of the Charity, spoke about the importance of early diagnosis for cancer treatment and how the new Oak Cancer Centre will improve this. The Duke told the assembled guests: “I have been privileged to be President of The Royal Marsden for over 10 years. It is a very special place to me – from my early visits as a young boy; to my work experience in 2007; and now my role as President. “The people who will benefit from the Oak Cancer Centre are cancer patients. Not only those who come through the doors of The Royal Marsden, but cancer patients across the UK and around the world. “I have met many of those patients on my visits to the hospital over the years, and on their behalf, I simply cannot thank you enough. What you are doing, what The Royal Marsden is doing, is immeasurably important.” RM RM magazine 17
RM36_p14-17_BP_v4.0.indd 17
05/09/2018 14:51
OA K’S M A JOR GIF T Thanks to the generosity of Oak Foundation and other donors, we are more than halfway to raising the £70 million we need to build a new centre for cancer research and care
THE DINNER AT Buckingham Palace (see page 14) was our way of saying ‘thank you’ to the philanthropists whose generosity is making our new £70-million care and research centre a reality. We can now announce that the building – previously referred to as the Clinical Care and Research Centre – will be officially known as the Oak Cancer Centre, named after Oak Foundation, which pledged the lead gift of £25 million. Due to open in 2021, the Oak Cancer Centre will place more than 300 pioneering researchers alongside patients with the most challenging and rare cancers, ensuring patients are at the heart
of research and helping to speed up the development of new treatments to improve survival rates. In its most ambitious appeal to date, The Royal Marsden Cancer Charity is aiming to raise the entire £70 million needed to build the new centre. Property expert Mike Slade is at the helm of an appeal board tasked with raising the money. The £25-million gift is the largest single donation to the Charity to date, and takes the total amount donated by Oak Foundation over the 15 years it has supported The Royal Marsden to an exceptional £43 million. Alan and Jette Parker, who established Oak Foundation
18 RM magazine
RM36_p18-19_oak_v3.0.indd 18
10/09/2018 17:36
OAK CANCER CENTRE
in 1983 to support non-profit organisations throughout the world, met HRH The Duke of Cambridge at the Buckingham Palace dinner alongside their granddaughters Chloe and Benedikte Turner. Professor David Cunningham, Director of Clinical Research at The Royal Marsden, says: “I’d like to thank Oak Foundation for this incredibly generous gift. Through pioneering new treatments and proving their effectiveness, the work carried out in the Oak Cancer Centre will benefit patients not just at The Royal Marsden, but also throughout the UK and beyond.” By using the latest and best possible technology in state-of-the-
STALWART SUPPORT Oak Foundation has funded drug development (top) and the Oak Centre for Children and Young People (above and top right); artist’s impression of the Oak Cancer Centre (opposite)
art treatment facilities, the Oak Cancer Centre will provide patients with earlier and faster diagnoses to increase the chances of survival. HRH The Duke of Cambridge, President of The Royal Marsden, launched the appeal in 2015. In a video message at the time, he said: “Over the years, The Royal Marsden has made some of the most extraordinary breakthroughs in cancer research. This has been made possible thanks to support from The Royal Marsden Cancer Charity. “This fantastic new building will provide a combination of modern and comfortable patient treatment areas as well as spaces designed to encourage learning and innovation amongst some of the world’s best clinical researchers.” The contemporary design, led by Project Director Hamish McKenzie, who led the building of The Shard, will offer patients a welcoming, peaceful and well-organised environment as well as access to the best possible treatment and care. RM
Want to know more?
OAK FOUNDATION SUPPORT It donated the lead gift of £8 million for The Royal Marsden’s Oak Centre for Children and Young People, which was opened by TRH The Duke and Duchess of Cambridge in 2011 It has funded the Oak Paediatric Drug Development Team for 15 years Its generosity made the Oak Foundation Drug Development Unit possible
Visit royalmarsden.org/appeal RM magazine 19
RM36_p18-19_oak_v3.0.indd 19
05/09/2018 14:24
A DAY IN T HE L IF E OF
NADIA FRERI S TAFF NURSE, PAEDIAT RICS
I AM ONE OF 30 nurses who work three to four 12-hour shifts a week on McElwain Ward, in the Royal Marsden Cancer Charity-funded Oak Centre for Children and Young People. Here, we look after inpatients between the ages of one and 15. Some stay with us for months at a time, and most will be having chemotherapy, radiotherapy or stem cell transplants. I can’t think of another job that would be as rewarding as mine. I joined The Royal Marsden four years ago as I’d heard so many good things about the patient care. Every day, my colleagues and I make a difference to children’s lives, and now I couldn’t imagine working anywhere else. A special relationship One of the best things about working with children is that they are so resilient; they can be very ill and then be running around the ward a few hours later. I also love the way children will tell you exactly how it is, and don’t have the capacity to feel sorry for themselves. They quickly realise that I’m here to make them feel
better, and that makes for a really special relationship. Of course, it can be difficult at times, and the Trust’s psychology team holds regular meetings with ward staff to offer us support. If I am working a day shift, I start at 8am and will be one of seven nurses on duty, and each of us will be allocated three patients to look after. We start the day with a handover from the night nurses. They brief us on each patient and how their night was, which helps me plan my day,
20 RM magazine
RM36_p20-21_DITL_v3.0.indd 20
07/09/2018 15:47
A D AY I N T H E L I F E
and update us on any additional needs the patients have. I administer treatment according to each patient’s individual schedule – there are no drugs rounds like you would see on an adult ward. Everything we do is bespoke for the children’s needs, and the medication can vary from chemotherapy to anti-sickness drugs. I take observations at regular intervals, usually every four hours, which involves taking my patients’ temperature, respiratory rate, blood pressure and pulse rate. I sometimes have to carry out observations on patients every 15 minutes if they’re seriously ill. I keep a calm head as it is what I am trained to do, and I know if I ever need help there will be someone at my side immediately. The value of play If I feel one of my patients needs extra support, I liaise with the play specialists, who are also funded by the Charity, thanks to a grant from the Chancellor of the Exchequer using LIBOR funds. The play specialists use things
“Every day, my colleagues and I make a difference to children’s lives” HERE TO HELP Nadia offers bespoke care to each of her young patients, administering treatment and observing their progress. Collaboration and communication with collegues is key
like games, activities and puzzles to distract the young patients, or prepare them for the procedure I need to carry out. We have monthly team meetings to discuss how we can improve our ways of working. I like the fact that everyone has a voice and can make a valid contribution. There are so many magical parts of my job, but seeing a child who has been in isolation for weeks due to their treatment come out and be able to go home is quite something. RM RM magazine 21
RM36_p20-21_DITL_v3.0.indd 21
05/09/2018 14:16
SMART WORK The technology behind big data and artificial intelligence allows us to assess vast amounts of data more efficiently – enabling smarter, quicker, tailor-made treatments for cancer patients
ALTHOUGH THE CONCEPT of artificial intelligence (AI) has existed since 1956, it’s only now that its use has become the norm. Earlier this year, Prime Minister Theresa May put AI and big data in the spotlight when she called for technology to transform how the UK prevents, diagnoses and treats cancer. Big data is often cited as the fuel that powers AI, and healthcare providers are uniquely placed to use the large amounts of data collected from patients as part of their care, as well as information gathered from clinical trials. At The Royal Marsden, our experts are exploring the latest advances in technology to help diagnose cancer earlier and improve the quality of life for patients living with cancer. As part of a groundbreaking project, Dr Christina Messiou, Consultant Radiologist, is working with Professor Andrea Rockall and Dr Ben Glocker from Imperial College London to develop machine learning that will assist radiologists
in reporting whole-body MRI scans in patients with myeloma. Machine learning is a type of AI in which computers are taught how to do things independently – for example, to identify scans that show evidence of cancer from healthy images. “If we want to truly understand a patient’s cancer, we often need to assimilate vast amounts of information, drawing on huge and complex datasets,” says Dr Messiou. “Radiology has always been a technology-driven specialism and AI is another really powerful tool to help us do our jobs better. With colleagues at Imperial College London, we’re developing state-of-the-art technology that will enable us to analyse this information much faster.” Improving quality of life Unlike CT scans, whole-body MRI scans can detect cancer in the bone marrow before it has caused destruction of the outer bone cortex,
meaning a diagnosis can be made much earlier. This is particularly important in myeloma because, as the disease progresses, it can result in irreparable bone damage, leading to debilitating complications. “The challenge with using whole-body MRI scans is that they generate a vast amount of data – around 1,000 images for each scan, which need to be examined individually by a radiologist,” says Dr Messiou. “This is where we’re turning to AI, to remove some of these more time-consuming tasks. “By developing a system that can flag up sites of possible disease and measure the amount of disease, we can get to work quicker on diagnosing and treating our patients, guided by extremely precise measurements.” The new study with Imperial, MALIMAR (Machine Learning in Myeloma Response), funded by the National Institute for Health Research (NIHR), will train a computer algorithm to recognise >
22 RM magazine
RM36_p22-24_ai_v5.0R.indd 22
10/09/2018 16:41
B I G DATA & A I
DATA DRIVEN Consultant Radiologist Dr Christina Messiou
RM magazine 23
RM36_p22-24_ai_v5.0R.indd 23
10/09/2018 16:41
B I G DATA & A I
STUDY TIME Professor Andrea Rockall and Dr Messiou (left) are collaborating on a project to use artificial intelligence to process wholebody MRI scans; Professor Winette van der Graaf (below left)
the difference between a healthy scan and a patient with myeloma. Researchers will then examine the time it takes to process and report whole-body MRI scans normally, compared with a radiologist using machine-learning technology. The study also aims to find a way to quantify the amount of disease visible on whole-body MRIs. “Big data is collaborative by its very nature, and this study will draw on expertise from radiologists, physicists, data scientists and computer scientists, as well as the machine-learning group at Imperial,” says Professor Rockall, who is an Honorary Consultant Radiologist at The Royal Marsden and Clinical Chair in Radiology at Imperial. “We
“Utilising smart analysis tools will support clinical decision-making” hope AI will not only detect and quantify the amount of disease, but also reduce the time needed for a radiologist to review the entire scan. This might allow whole-body MRI to become a test that can be readily offered to myeloma patients throughout the NHS.” Routine procedures Our researchers are also developing the big-data computing infrastructure that will underpin all research at the Trust, across all cancer types. Professor Winette van der Graaf, who is leading this work as part of the Digital theme at the NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, says: “Our vision is to provide smarter, kinder treatments, tailored to individual patients. This can only be achieved through rapidly accessing all relevant data for
a patient and utilising smart analysis tools to support clinical decision-making.” A new data management system called PROFILES, which has been used in the Netherlands since 2009, will collect anonymous data on Patient Reported Outcome Measures (PROMs). “The challenge is embedding this technology and capturing this information in a routine way, as part of a patient’s clinical records, in order to guide our clinical decisions,” says Professor van der Graaf. “In the shorter term, we’re already using this technology to better understand the care needs of young adults with cancer.”
Professor van der Graaf, Dr Olga Husson and colleagues have written to all patients aged 25-39 who have been diagnosed with cancer in the past five years at The Royal Marsden and other hospitals in London, Ipswich and Southampton. Through focus groups, interviews and surveys, the study will measure care needs and experiences, quality of life, psychological distress and the wider impact of cancer. “These patients are confronted with a life-threatening disease, alongside the usual challenges of careers, finances, partners, fertility and young children,” says Professor van der Graaf. “By interrogating large amounts of data, we want to move oncology into the digital age by exploring young people’s digital preferences, and develop clinical pathways of the future.” The results will be used to design a tool or service, such as a digital app, to support young adults with cancer at the Trust. The possibilities for harnessing this technology in cancer care are endless, and The Royal Marsden is just beginning to explore them. RM
Want to know more? Visit cancerbrc.org/our-research for more about our digital work
24 RM magazine
RM36_p22-24_ai_v6.0R.indd 24
13/09/2018 13:36
IT HAPPENED TO ME
I WAS TOLD I MIGHT ONLY HAVE TWO YEARS LEFT TO LIVE. NOW SCANS SHOW I HAVE NO SIGNS OF CANCER Julie Morawaka, 55, bladder cancer patient
THE FIRST TIME I stood on the steps outside The Royal Marsden, I cried. But the moment I stepped in and experienced how everyone is so positive and happy here, I knew I was in the best hands. I was diagnosed with an aggressive form of bladder cancer in August 2016. I’d been having regular urinary tract infections since December 2015; although my GP said there was nothing to worry about, I was concerned,
so pressed for further scans. These results came back showing an aggressive tumour, which had progressed into the muscle of my bladder. I was told that, without further treatment, I might only have two years left to live. After initial surgery at another hospital, surgeons there referred me to The Royal Marsden; they said that it was the best cancer hospital in the world, with amazing care and treatment.
My consultant surgeon, Mr Pardeep Kumar, arranged for me to have two cycles of chemotherapy, but my tumour didn’t respond. Despite this, Mr Kumar gave me hope in the form of radical surgery. During the operation, Mr Kumar removed my bladder, some lymph nodes, part of the vagina and performed a hysterectomy. He also carried out a Mitrofanoff procedure, where he used part of the intestine to create a ‘channel’ through which urine can pass out of the body, via a catheter in my belly button. It’s thanks to this pioneering treatment that I’ve been able to avoid wearing a urostomy bag; other than my scar you would hardly know what has happened. This has had such a positive impact on me and my confidence; by having the Mitrofanoff procedure I can lead as ‘normal’ a life as possible, despite having my bladder removed. Nearly two years on from my operation, my scans show that I have no signs of cancer, which is just amazing. If it wasn’t for The Royal Marsden, Mr Kumar and the fantastic theatre team, I simply wouldn’t be here. I’m a big supporter of The Royal Marsden Cancer Charity too – at every opportunity, I encourage my friends and family to support them to make sure The Royal Marsden can continue to perform the life-saving work they do. RM
Mr Pardeep Kumar
Consultant Urological Surgeon “I am delighted that Julie’s scans show no signs of cancer and that her new bladder is working so well. “The Mitrofanoff procedure has enabled Julie to maintain an excellent quality of life. We are one of a few centres in the country that can offer the type of pioneering operation that Julie underwent, which has proven effective in treating the particularly aggressive and unusual tumour that she had. “Bladder cancer is the ninth most common cancer in the UK but attracts much less funding for research than other cancers. I am pleased that she is raising awareness of bladder cancer, especially through her fundraising for The Royal Marsden Cancer Charity.”
“The Mitrofanoff procedure has had such a positive impact on my confidence” RM magazine 25
RM36_p25_ihtm_v3.0.indd 25
05/09/2018 12:48
A million thanks to Ralph Lauren TO MARK THE 50TH anniversary of Ralph Lauren and to kick off the 2018 Pink Pony campaign, the luxury global brand has announced an amazing donation of $1 million to The Royal Marsden Cancer Charity. The money was raised by the generosity of Ralph Lauren customers across Europe, who have the ongoing opportunity to donate at the point of sale via electronic tablets. The company has a longstanding relationship with the Charity. Mr Ralph Lauren opened the Ralph Lauren Centre for Breast Cancer Research at The Royal Marsden alongside HRH The Duke of Cambridge in 2016, and employees raise funds throughout the
year, taking part in sporting events and sponsored walks in London. This is in addition to the annual Pink Pony campaign every October, in which a percentage from sales of the Pink Pony collection is donated to charities around the world, with The Royal Marsden Cancer Charity being the UK recipient. Antonia Dalmahoy, Director of The Royal Marsden Cancer Charity, said: “We are so grateful to Ralph Lauren for their continued support and this most recent donation. It is thanks to their help that we are able to make a real difference for people with cancer.”
Want to know more? Look out for #PinkPony on social media
Getting shirty for Father and Son Day FATHER AND SON DAY founders Daniel Marks and Jack Dyson model shirts from online fashion retailer Mr Porter. The proceeds from the shirts’ sales – and those of T-shirts by Orlebar Brown – will be donated to The Royal Marsden Cancer Charity. So far this year, the Father and Son Day campaign, which is all about inspiring men and dealing with male cancer, has raised £35,000 for the Charity, taking the total raised to over £220,000. Find out more at fatherandsonday.com
Keep on running: in memory of Nicola After being diagnosed with bowel cancer in 2 0 1 3 , Nicola Murrells, together with her friends and family, raised an amaz ing £ 1 .8 million for The Royal Marsden Cancer Charity to fund research into immunotherapy. Nicola sadly passed away in September last year, but fundraising has continued, with her brother Gregg now leading the charge. Gregg recently ran 1 1 4 miles to help fund the ‘ Nicola Murrells Immunotherapy Research Team’ at The Royal Marsden, raising more than £ 9 ,0 0 0 . Gregg said: “It makes me feel incredibly proud but is of course a reminder that my sister, the driving force behind it all, is no longer here. I’m excited to take our fundraising to the next level.” Professor D avid Cunningham, who will lead the team, said: “I’m incredibly grateful to Nicola, her family and supporters for opening up this maj or research avenue, allowing us to run additional studies and fund several new posts.”
Want to know more? Donate at justgiving.com/ fundraising/nicola-murrells
26 RM magazine
RM36_p26-27_Fundraising_v4.0.indd 26
07/09/2018 16:31
T H E R O YA L M A R S D E N C A N C E R C H A R I T Y
FORWARD, MARCH! WE’RE THRILLED TO announce that Banham, who have sponsored The Marsden March since 2015, have confirmed a further three-year sponsorship, taking its involvement to 2021. The Banham Marsden March opens for registration
on 1 October, and takes place on 10 March 2019. Royal Marsden patient Chris Lee used this year’s Marsden March as his post-surgery and end-of-treatment goal. The bond broker, who was diagnosed with a rare
READY TO MARCH Chris Lee at the start line
gastrointestinal stromal tumour (GIST) in March 2017, started walking a few miles each day and found that the training helped him regain his fitness. Chris said: “After treatment, all I could do to exercise was walk, so I thought I would show my gratitude to the hospital and raise some money.” Chris went on to raise nearly £18,000 in sponsorship, making him the highest single fundraiser in 2018. He said: “The atmosphere was electric at the start line. The walk was a lot of fun and testing for me, given that I only had major surgery three months before. I walked alone but met so many interesting people walking on behalf of loved ones and people who were in remission.” Marsden Marchers have raised almost £12 million since 2011 to improve the lives of everyone affected by cancer.
Want to know more? To register, go to royalmarsden.org/march
Hair raising To mark what would have been Philip Kingsley’s 88th birthday, on 7 June this year, philipkingsley.co.uk and the Philip Kingsley trichological clinic in Mayfair donated turnover from product sales on the day to The Royal Marsden Cancer Charity. The Charity was a cause close to Philip’s heart due to his wife Joan’s experience with breast cancer. His No Scent, No Colour range was one of the first product lines in the world specifically developed to suit the needs of people undergoing chemotherapy and
radiotherapy. Since Philip passed away, his family have continued to support the Charity. His daughter, Anabel Kingsley, said: “It is our wish to continue the legacy of my father, not only through our award-winning clinics and product range, but also through partnerships with charities such as The Royal Marsden Cancer Charity.” The donations will help to fund Mr Gerald Gui’s groundbreaking research into genetic predisposition to breast cancer and better ways to treat it.
Contact The Royal Marsden Cancer Charity Telephone 020 8770 0279 Email charity@royalmarsden.org Visit royalmarsden.org Registered Charity No. 1095197
Polo minted The Royal Marsden Cancer Charity was one of two beneficiaries of the Maserati Royal Charity Trophy in June, as our President, HRH The Duke of Cambridge, took to the field at the Gloucestershire Festival of Polo at Beaufort Polo Club on the winning Maserati team. Funds were also raised through the Javier Novillo Astrada U15 Cup, which was played ahead of the main match, bringing the total to £125,000 – to be shared equally with charity Centrepoint. Royal Marsden Cancer Charity supporters Vicki and James Woodall, who are behind the £1-million fundraising campaign George and the Giant Pledge, were guests. Vicki said: “It was wonderful to be able to speak to guests about the work of the hospital and our fundraising, and take part in the trophy presentation.” Mark Tomlinson, one of the directors of the club, said: “The festival was one of the most successful we have had. Everyone involved should be very proud to have raised such an impressive amount.”
RM magazine 27
RM36_p26-27_Fundraising_v4.0.indd 27
05/09/2018 17:09
IN FOND MEMORY OF DR PETER LEWINS
IN T RODUCING T WO NE W BOA RD MEMBERS We welcome William Jackson and Chris Clark as NEDs WE ARE PLEASED to announce that two new Non-Executive Directors (NEDs) are joining The Royal Marsden Board. William Jackson is Managing Partner of Bridgepoint, a leading international private equity group. He is a NED and Senior Independent Director at British Land, and President of the Board at Dorna Sports SL, the rights holder for MotoGP. Until recently, he was also Chairman of the Board at Pret A Manger. William said: “The Royal Marsden’s reputation precedes it. The staff and patients I have spoken to so far have reinforced that this is a centre of excellence and a very special place indeed.” Also joining the Board is Chris Clark, who until late 2017 was the Group Head of Marketing at
HSBC. Chris said: “Twenty-five years ago, I was diagnosed with retinal melanoma, an aggressive form of cancer that left me blind in my right eye. On the basis of that, over the years I’ve got involved with a variety of cancer organisations. “When this opportunity with The Royal Marsden came along, I knew I’d be disappointed if I didn’t get it. The spirit the management team has is quite infectious.”
ON BOARD William Jackson (above left) and Chris Clark
W e would like to pay tribute to our Patient and L ead Governor D r Peter L ewins, who sadly passed away in May 2 0 1 8. As a GP for 2 4 years in southeast L ondon, Peter had been involved in GP education and training and in the provision of end-of-life care throughout his career. He continued this work in his role as a Royal Marsden Patient Governor, working with The Royal Marsden’s GP E ducation and Coordinate My Care teams. Peter fully immersed himself in his Governor role, was a representative on many groups and committees and was an ambassador for The Royal Marsden Cancer Charity. W e are incredibly grateful for Peter’s contribution over the past five years he will e greatly missed by everyone who was lucky enough to work with him.
“The Royal Marsden is a very special place indeed”
28 RM magazine
RM36_p28-29_Foundation_v4.1R.indd 28
13/09/2018 13:38
F O U N DAT I O N N E W S
IMPROVING A ND INNOVAT ING Find out what advances are being made across the Trust KEEPING YOU INFORMED Eamonn Sullivan (left) and Jatinder Harchowal
Dates for your diary Board of Directors meeting 26 September 2018, Chelsea Annual General Meeting 26 September, 5.30pm-7.30pm, Chelsea Council of Governors meeting 3 October, 11am-1pm, Sutton
OUR NEXT MEMBERS’ event is being held on 8 November 2018 in Chelsea. Hosted by Eamonn Sullivan, Chief Nurse, the event will focus on establishing our quality improvement priorities for 2019-20. Members will hear from guest speakers Jatinder Harchowal, Chief Pharmacist, and Emma Foreman, Consultant Pharmacist.
SUMMER MEMBERS’ EVENT
They will give an update on the latest developments in targeted cancer drugs and how they will shape the future management of cancer patients – including cell-signalling inhibitors, immunotherapy and the latest CAR-T cell treatments. Emma Masters, Advanced Nurse Practitioner for Teenagers and Young Adults, will talk about
The Trust held a members’ event in the summer at Chelsea that featured a talk from D r Naureen Starling, Consultant Medical O ncologist, on Innovating for atient enefit linical esearch at he oyal arsden and its ider pact Members also heard from Antonia al ahoy ana in irector of he oyal arsden ancer harity while r atalie oyle urse onsultant ivin ith and eyond
the advances and innovations in teenage and young adult care at The Royal Marsden. Members’ events are free to attend and open to everyone.
Want to know more? Please contact Rebecca Hudson, Members and Governor Lead, on 020 7808 2844 or email trust.foundation@rmh.nhs.uk
ancer presented on the role of holistic needs assess ents in i provin uality of life for people with cancer e ers who attended provided very positive feed ac ne attendee said hese events are a reat platfor to socialise and hear about innovations happenin at he oyal arsden e would li e to than the spea ers for helpin to a e the event such a success and the members for attending.
Council of Governors meeting 12 December, 11am-1pm, Chelsea To attend any of these meetings, please call 020 7808 2844 or email trust. foundation@ rmh.nhs.uk
Keep in touch To contact your Governor, email governors@ rmh.nhs.uk or telephone 020 7808 2844. Sign up and become a member at royalmarsden. nhs.uk/ membership RM magazine 29
RM36_p28-29_Foundation_v4.1.indd 29
05/09/2018 12:25
PUZZLES & PRIZES
PRIZE CROSSWORD
The lucky winner of our prize crossword will receive a £50 John Lewis gift card. Send your crossword with your name and contact details to RM, PR and Communications Team, The Royal Marsden, Fulham Road, Chelsea, London SW3 6JJ. The entry closing date is Monday 16 October 2018. See below for prize draw rules. Summer 2018 crossword solution Across 1 Ruler 4 Nacre 6 Siamese 8 Duck 9 Large 12 Rebut 13 Claw 15 Pharaoh 17 Beech 18 Wades Down 1 Round trip 2 Lion cub 3 Rose 4 Nearly 5 Cue 7 Edelweiss 10 Related 11 Attach 14 Dhow 16 Ate Congratulations to Mr Peter Harris, the winner of the summer 2018 issue’s crossword prize. 1
2
6
3
4
5
7
9
8
11
12
10
14
13
15
16
17
AUTUMN 2018 PRIZE CROSSWORD ENTRY FORM Fill in your details below when sending in your crossword competition entry. See above for details of our address. NAME ADDRESS
POST CODE TELEPHONE
SUDOKU
THE TEAM
Try the fiendishly tricky numbers puzzle – it’s just for fun
FOR THE ROYAL MARSDEN
5
9 4
3
5
5 7 1 9 5 3 7 6 5 1 9 8 7 3 2 4 9 8 6 1 4 6 2 8 3
CROSSWORD CLUES Across 1 Pedigree dog (6,5) 6 A lowly, mixed-breed dog (3) 7 Inhabitant of Mediterranean country (7) 8 Instruct (5) 9 Male duck (5) 11 Musical composer (5) 13 Dinners, maybe (5) 15 A type of varnish (7) 16 Poem (3) 17 To a greater degree than is necessary (11)
Down 1 Race course (5) 2 European country (7) 3 American sect (5) 4 Obsessively store things (5) 5 Move to music (5) 10 Shellfish (7) 11 Divide in two (5) 12 Grammatically describes things or people (5) 13 French thank you (5) 14 A bit squalid (5)
PRIZE DRAW TERMS AND CONDITIONS 1. The Prize Draw is open to all readers of RM except employees of the Press Office at The Royal Marsden and Sunday, who produce RM magazine. 2. The closing date for receipt of all entries is Monday 16 October 2018. Only one entry per person per draw. 3. Responsibility cannot be accepted for entries that are incomplete, illegible or not received. Proof of posting is not proof of receipt. No cash alternative is available and prizes are not transferable. Value of prize is correct at time of going to press. 4. Winners will be notified by post within 14 days of closing date.
5. The Promoter’s decision on any aspect of the promotions is final and binding. No correspondence will be entered into. 6. The Promoter reserves the right to substitute a prize of equal or greater value should circumstances make this necessary. 7. Entry implies acceptance of rules. 8. The winner of the crossword prize of a £50 John Lewis gift card will be the first correct entry drawn out of the bag. 9. The Promoter is The Royal Marsden, Fulham Road, London SW3 6JJ.
Rachael Reeve Director of Marketing and Communications Elaine Parr Head of PR and Communications Abby Samuel PR and Communications Manager Catherine O’Mara Senior PR and Communications Officer Belinda Lock Senior PR and Communications Officer Hannah Bransden Senior PR and Communications Officer Jack Stonebridge Senior PR and Communications Officer
FOR SUNDAY Marc Grainger Editor Mark Wheeler Art Director Sian Purdy Designer Gill Tait Account Director Richard Robinson Group Editor Matt Beaven Creative Director Toby Smeeton Managing Director RM magazine is published by The Royal Marsden in partnership with Sunday: wearesunday.com © The Royal Marsden 2018. All rights reserved. Reproduction in whole or part is prohibited without prior permission of the Editor. The Royal Marsden and Sunday accept no responsibility for the views expressed by contributors to the magazine. Repro by F1 Colour. Printed by Pureprint.
30 RM magazine
RM36_p30-31_puzzles_media_v2.0.indd 30
05/09/2018 11:44
S TAY I N T O U C H
COMMENT, LIKE, SHARE Join the conversation at twitter.com/royalmarsden twitter.com/royalmarsdenNHS facebook.com/royalmarsden Twitter
Louise Stewart @FSBLouiseS This # CancerSurvivorsD ay I am so grateful to be in remission and pay thanks to my surgeon Miss F iona MacNeill [ pictured on the left] @ royalmarsden # L ondonB reastClinic who made it possible The Urban Kitchen @urbankitchen Huge thanks to @ royalmarsdenNHS for being absolutely fabulous today and taking my concerns seriously when there for my annual tests. V ery pleased to be looked after @ GeraldGui1 team, even though it is 1 2 years tmrw since I had my mastectomy.
Vivienne Porritt @ViviennePorritt I need to thank you. Y our doctors and nurses are incredible people who deal with pain and fear everyday and yet are so positive, skilled and sensitive to people’s needs. W ords aren’t enough to describe what they do. # NHS.
Kelly Gurney I had the pleasure of being able to visit this [ Pandora courtyard garden] today, my daughter had a swing in the chairs and I got to shoot a few hoops! It looks absolutely beautiful and a really great place for some q uiet contemplation when you need it and also a place to let o so e stea if necessary Natalie Hoegen I feel truly lucky to have the support of kind and skilled Clinical Nurse Specialists like L aura and Sarah. They have gotten me through the year plus of this j ourney with all the rollercoaster events that go with it. I am lucky to have
met them, albeit without the breast cancer would have been nice too! Michelle Stepney Thank you the NHS and The Royal Marsden for saving my life whilst pregnant with cancer. Thank you for keeping our twin girls alive. A massive THANK Y O U
CONTACT US CALL THE ROYAL MARSDEN, CHELSEA
020 7352 8171
CALL THE ROYAL MARSDEN, SUTTON
CONTACT THE ROYAL MARSDEN HELP CENTRE For confidential chat, support and information, call
020 8642 6011
0800 783 7176
VISIT US ONLINE royalmarsden.nhs.uk
or visit royalmarsden.nhs.uk/your-care/ royal-marsden-help-centre
WANT TO WORK AT THE ROYAL MARSDEN? Visit jobs.royalmarsden.nhs.uk READ RM MAGAZINE ONLINE royalmarsden.nhs.uk/rm-magazine
For general feedback, compliments, concerns or complaints, send us a message royalmarsden.nhs.uk/ contact-us/get-in-touch
STAY IN TOUCH WITH THE ROYAL MARSDEN CANCER CHARITY CALL US
020 8770 0279 EMAIL US charity@royalmarsden.org VISIT US ONLINE royalmarsden.org Registered Charity No. 1095197
Look out for the winter 2018 issue of RM – coming November 2018 RM magazine 31
RM36_p30-31_puzzles_media_v2.0.indd 31
05/09/2018 11:44
Registered Charity No. 1095197
Together we walk Sign up today and proudly walk amongst thousands of fellow supporters on 10 March 2019 for The Royal Marsden Cancer Charity. Whether you choose the 5 or 15 mile route, every step you take will help raise vital funds that make a big difference to the lives of cancer patients everywhere. Sign up at royalmarsden.org/march RM36_p32_OBC_v1.0.indd 32
05/09/2018 11:41
